Your browser doesn't support javascript.
loading
The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.
Jaeger, B A S; Neugebauer, J; Andergassen, U; Melcher, C; Schochter, F; Mouarrawy, D; Ziemendorff, G; Clemens, M; V Abel, E; Heinrich, G; Schueller, K; Schneeweiss, A; Fasching, P; Beckmann, M W; Scholz, Ch; Friedl, T W P; Friese, K; Pantel, K; Fehm, T; Janni, W; Rack, B.
Afiliação
  • Jaeger BAS; Department of Gynecology and Obstetrics, Heinrich-Heine-University Hospital, Duesseldorf, Germany.
  • Neugebauer J; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Hospital, Munich, Germany.
  • Andergassen U; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Hospital, Munich, Germany.
  • Melcher C; Department of Gynecology and Obstetrics, Heinrich-Heine-University Hospital, Duesseldorf, Germany.
  • Schochter F; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Mouarrawy D; Hospital Bremerhaven-Reinkenheide, Bremerhaven, Germany.
  • Ziemendorff G; Hospital Ludwigsburg, Ludwigsburg, Germany.
  • Clemens M; Krankenanstalten Mutterhaus der Borromäerinnen, Trier, Germany.
  • V Abel E; Hospital Schwäbisch Gmuend, Mutlangen, Germany.
  • Heinrich G; Praxis Dr. Heinrich, Fuerstenwalde, Germany.
  • Schueller K; Stat-up Statistische Beratung und Dienstleistung, Munich, Germany.
  • Schneeweiss A; Department of Gynecology and Obstetrics in the National Center for Tumor Disease, University Hospital Heidelberg, Heidelberg, Germany.
  • Fasching P; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Scholz C; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Friedl TWP; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Friese K; Hospital Bad Trissl, Bad Trissl, Germany.
  • Pantel K; Institute for Tumor Biology, Center of Experimental Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fehm T; Department of Gynecology and Obstetrics, Heinrich-Heine-University Hospital, Duesseldorf, Germany.
  • Janni W; Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany.
  • Rack B; Department of Gynecology and Obstetrics, Ludwig-Maximilians-University Hospital, Munich, Germany.
PLoS One ; 12(6): e0173593, 2017.
Article em En | MEDLINE | ID: mdl-28586395
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Receptor ErbB-2 / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Biomarcadores Tumorais / Receptor ErbB-2 / Células Neoplásicas Circulantes Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Alemanha